OTLK Latest Quarter’s Earnings
Announce Date8/14/2026
EPS Actual (USD)-0.15
Revenue Actual (USD)8.70K
Outlook Therapeutics Inc Earnings Dates & Reports
This page offers detailed Outlook Therapeutics Inc earnings data including the latest Outlook Therapeutics Inc earnings report, the upcoming Outlook Therapeutics Inc earnings date, historical data and Outlook Therapeutics Inc earnings call news.
OTLK Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
OTLK FY2025 Earnings
EPS (YoY)-1.7955.85%
Revenue (YoY)1.41M--
Outlook Therapeutics Inc (OTLK) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 8/14/2026 | 09/2026 | -0.15/-0.09 | 8.70K/5.30M | -71.44% | -99.84% |
| 5/15/2026 | 06/2026 | -0.05/-0.12 | 127.44K/4.40M | 54.66% | -97.10% |
| 2/17/2026 | 03/2026 | -0.38/-0.17 | -1.21M/5.03M | -120.96% | -124.04% |
| 12/19/2025 | 12/2025 | -0.28/-0.25 | --/5.85M | -11.19% | -- |
| 8/14/2025 | 09/2025 | -0.55/-0.39 | 1.51M/1.66M | -38.64% | -9.45% |
| 5/15/2025 | 06/2025 | -1.50/-0.60 | --/702.60K | -151.08% | -- |
| 2/14/2025 | 03/2025 | 0.72/-0.78 | --/0.00 | 192.53% | -- |
| 12/27/2024 | 12/2024 | 0.24/-0.83 | --/0.00 | 128.76% | -- |
Outlook Therapeutics Inc Latest Earnings Call Transcripts
Outlook Therapeutics (OTLK) Fiscal Q3 2026 Earnings Call: LYTENAVA Launch and Revenue Guidance
Outlook Therapeutics’ fiscal Q3 2026 earnings call covered LYTENAVA’s FDA approval, U.S. launch plans, $50M-$75M first-year revenue guidance and financing.